Handbook of Clinical Nanomedicine, Two-Volume Set Multiple-component retail product

Pan Stanford Series on NanomedicineDiversity within the broad and evolving arena of nanomedicine and nanopharma is reflected in the expertise of the distinguished contributing authors.

The chapters contain key words, figures in full-color and an extensive list of references.

As compared to texts on the market, each handbook in the series is comprehensive and intended to be a stand‐alone reference resource, presented in a user-friendly format for easy access.

The editors have skillfully curated each chapter to reflect the most relevant and current information possible.

The range of topics covered as well as the multidisciplinary approach of the handbooks will attract a global audience.

The handbooks are essential reading for both the novice and expert in fields ranging from medicine, biotechnology, pharmaceutical sciences, engineering, FDA law, intellectual property, policy, future studies, ethics, licensing, commercialization, risk analysis, and toxicology. Handbook of Clinical Nanomedicine. Vol. 1. Nanoparticles, Imaging, Therapy, and Clinical Applications, Raj Bawa, PhD, Gerald F.

Audette, PhD, and Israel Rubinstein, MD (Editors)This handbook (55 chapters) provides a comprehensive roadmap of basic research in nanomedicine as well as clinical applications.

However, unlike other texts in nanomedicine, it not only highlights current advances in diagnostics and therapeutics but also explores related issues like nomenclature, historical developments, regulatory aspects, nanosimilars and 3D nanofabrication.

While bridging the gap between basic biomedical research, engineering, medicine and law, the handbook provides a thorough understanding of nano’s potential to address (i) medical problems from both the patient and health provider's perspective, and (ii) current applications and their potential in a healthcare setting. Handbook of Clinical Nanomedicine. Vol. 2. Law, Business, Regulation, Safety, and Risk, Raj Bawa, PhD (Editor), Gerald F.

Audette, PhD, and Brian E. Reese, PhD, MBA, JD (Assistant Editors)This unique handbook (60 chapters) examines the entire "product life cycle," from the creation of nanomedical products to their final market introduction.

While focusing on critical issues relevant to nanoproduct development and translational activities, it tackles topics such as regulatory science, patent law, FDA law, ethics, personalized medicine, risk analysis, toxicology, nano-characterization and commercialization activities.

A separate section provides fascinating perspectives and editorials from leading experts in this complex interdisciplinary field.